Propofol and Sevoflurane for Catheter-Related Bladder Discomfort
Conditions
Catheter Site Discomfort - Complications - Anesthesia - Urinary Bladder Neoplasms
Conditions: official terms
Urinary Bladder Neoplasms
Study Type
Interventional
Study Phase
N/A
Study Design
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Intervention
Name: Propofol Type: Drug
Name: Sevoflurane Type: Drug
Overall Status
Not yet recruiting
Summary
The investigators want to evaluate the efficacy of the propofol and sevoflurane for the prevention of catheter-related bladder discomfort.
Detailed Description
The mechanism of catheter-related bladder discomfort is thought to be related to the muscarinic receptor. Propofol and desflurane are most widely used as an anesthetic agent. Propofol and desflurane are known to block the muscarinic receptor in different ways.

The investigators want to evaluate the efficacy of the propofol and sevoflurane for the prevention of catheter-related bladder discomfort.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 80 Years
Minimum Age: 19 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients scheduled for transurethral bladder excision under general anesthesia

- ASA I-III

Exclusion Criteria:

- Foley catheter less than 18 Fr.

- Patients with obstruction of urinary tract

- Patients with neurogenic bladder

- Patients with severe obesity

- Patients with neurologic disorder

- Patients with chronic pain

- Patients with allergic history to propofol or sevoflurane
Location
Seolu National University of Hospital
Seoul, Korea, Republic of
Status:
Start Date
October 2014
Completion Date
March 2015
Sponsors
Seoul National University Hospital
Source
Seoul National University Hospital
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page